Age Wave Founder and CEO, Ken Dychtwald, PhD, will address rising longevity and the important role that disruptive medical technology plays to this generation and beyond.
Professor Gail ter Haar, an expert in focused ultrasound and physics, is the recipient of this year’s Visionary Award.
She leads the therapeutic ultrasound team at The Institute for Cancer Research and is founding President of the International Society for Therapeutic Ultrasound.
At the meeting, she will address the future of therapeutic ultrasound and lessons to be learned from the past.
Sonodynamic therapy (SDT) uses focused ultrasound to activate agents that accumulate in tumor cells and cause cell death.
A recent comprehensive review discusses SDT for primary and metastatic tumors, the agents used, combination therapies, and proposed cellular mechanisms.
The profitability of focused ultrasound treatments is a critical decision point for those who are investing in devices for their treatment sites.
The Foundation has developed a tool to compare the cost of focused ultrasound to other standard-of-care therapies.
The tool is available to industry to assist in selling focused ultrasound technology to prospective customers and help guide future commercial endeavors.
